Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies - Chen, Tzu-Ting; Lin, Ching-Chan; Lo, Wen-Jyi; Hsieh, Ching-Yun; Lien, Ming-Yu; Lin, Che-Hung; Lin, Chen-Yuan; Bai, Li-Yuan; Chiu, Chang-Fang; Yeh, Su-Peng (International journal of hematology, 2022)
Keywords: Antilymphocyte serum; Antilymphocyte Serum - therapeutic use; Blood; Blood cancer; Calcineurin; Calcineurin inhibitors; Cyclophosphamide; Cyclophosphamide - therapeutic use; Disease prevention; Epstein-Barr virus; Epstein-Barr Virus Infections - drug therapy; Globulins; Graft versus host disease; Graft vs Host Disease - drug therapy; Graft vs Host Disease - etiology; Graft vs Host Disease - prevention & control; Graft-versus-host reaction; Hematologic Neoplasms - pathology; Hematology; Hematopoietic Stem Cell Transplantation - adverse effects; Hematopoietic stem cells; Herpesvirus 4, Human; Humans; Immunoproliferative diseases; Lymphocytes; Malignancy; Medicine; Medicine & Public Health; Oncology; Original Article; Peripheral blood; Peripheral Blood Stem Cell Transplantation - adverse effects; Prophylaxis; Rapamycin; Retrospective Studies; Stem cell transplantation; Stem cells; Strategy; Thymocytes; Transplantation; Transplantation Conditioning; ATG; Sirolimus; Haploidentical PBSCT